$CHEK
Check-Cap Ltd Stock $chek

$chek Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000121390024043550 Filed on May 15, 2024

Income Statement

Concept	2023 Q4	2023
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.955M	$9.462M
YoY Change	214.14%	67.56%
% of Gross Profit
Research & Development	$130.0K	$8.311M
YoY Change	-95.6%	-41.76%
% of Gross Profit
Depreciation & Amortization	$22.00K	$212.0K
YoY Change	-85.33%	-47.52%
% of Gross Profit
Operating Expenses	$4.085M	$8.311M
YoY Change	-3.08%	-41.76%
Operating Profit		-$19.29M
YoY Change		-3.73%
Interest Expense	$427.0K	$13.00K
YoY Change	-14.94%	8.33%
% of Operating Profit
Other Income/Expense, Net		$1.719M
YoY Change		85.64%
Pretax Income	-$3.658M	-$17.57M
YoY Change	-1.48%	-8.06%
Income Tax
% Of Pretax Income
Net Earnings	-$3.658M	-$17.57M
YoY Change	-1.48%	-8.06%
Net Earnings / Revenue
Basic Earnings Per Share		$3.00
Diluted Earnings Per Share	-$0.63	$3.00
COMMON SHARES
Basic Shares Outstanding	5.851M shares	5.849M shares
Diluted Shares Outstanding		5.849M shares

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.76M	$24.76M
YoY Change	-40.63%	-40.63%
Cash & Equivalents	$8.844M	$8.844M
Short-Term Investments	$15.91M	$15.91M
Other Short-Term Assets	$11.00K	$100.0K
YoY Change	-95.07%	-89.26%
Inventory
Prepaid Expenses	$35.00K
Receivables
Other Receivables
Total Short-Term Assets	$24.86M	$24.86M
YoY Change	-41.69%	-41.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$161.0K	$161.0K
YoY Change	-90.81%	-94.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$161.0K	$161.0K
YoY Change	-94.27%	-94.27%
TOTAL ASSETS
Total Short-Term Assets	$24.86M	$24.86M
Total Long-Term Assets	$161.0K	$161.0K
Total Assets	$25.02M	$25.02M
YoY Change	-44.95%	-44.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$141.0K	$141.0K
YoY Change	-85.19%	-85.19%
Accrued Expenses	$406.0K	$406.0K
YoY Change	-74.59%	-74.59%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.330M	$1.330M
YoY Change	-60.97%	-60.97%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Total Long-Term Liabilities		$0.00
YoY Change		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.330M	$1.330M
Total Long-Term Liabilities		$0.00
Total Liabilities	$1.330M	$1.330M
YoY Change	-67.79%	-67.79%
SHAREHOLDERS EQUITY
Retained Earnings	-$144.9M
YoY Change	13.8%
Common Stock	$83.75M
YoY Change	0.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$23.69M	$23.69M
YoY Change
Total Liabilities & Shareholders Equity	$25.02M	$25.02M
YoY Change	-44.95%	-44.95%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$3.658M	-$17.57M
YoY Change	-1.48%	-8.06%
Depreciation, Depletion And Amortization	$22.00K	$212.0K
YoY Change	-85.33%	-47.52%
Cash From Operating Activities	-$3.539M	-$16.95M
YoY Change	-14.66%	-9.37%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$83.00K
YoY Change	-100.0%	-82.92%
Acquisitions
YoY Change
Other Investing Activities	$8.870M	$21.44M
YoY Change	-967.91%	-278.33%
Cash From Investing Activities	$8.870M	$21.36M
YoY Change	-896.95%	-270.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities	-3.539M	-$16.95M
Cash From Investing Activities	8.870M	$21.36M
Cash From Financing Activities
Net Change In Cash	5.331M	$4.402M
YoY Change	-201.35%	-119.68%
FREE CASH FLOW
Cash From Operating Activities	-$3.539M	-$16.95M
Capital Expenditures	$0.00	$83.00K
Free Cash Flow	-$3.539M	-$17.04M
YoY Change	-16.49%	-11.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Entity File Number EntityFileNumber	001-36848
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	Check-Cap Ltd
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L3
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	29 Abba Hushi Avenue
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	P.O. Box 1271
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Isfiya
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	3009000
CY2023	dei	Entity Address Country EntityAddressCountry	IL
CY2023	dei	Entity Registrant Name EntityRegistrantName	Check-Cap Ltd.
CY2023	dei	Security12b Title Security12bTitle	Ordinary Shares, par value NIS 48.00
CY2023	dei	Trading Symbol TradingSymbol	CHEK
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5850770	shares
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Auditor Firm AuditorFirmId	1197
CY2023	dei	Auditor Name AuditorName	Brightman Almagor Zohar & Co.
CY2023	dei	Auditor Location AuditorLocation	Tel Aviv, Israel
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8844000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4090000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	352000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	15912000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	37609000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	100000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	579000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	24856000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	42630000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2811000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	161000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1751000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1060000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	161000	usd
CY2023Q4	us-gaap	Assets Assets	25017000	usd
CY2022Q4	us-gaap	Assets Assets	45441000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	141000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	952000	usd
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	783000	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	802000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	406000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1261000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	337000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	56000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1330000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3408000	usd
CY2022Q4	chek	Royalties Provision RoyaltiesProvision	94000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	627000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	721000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	48
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	48
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	18000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	18000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5850555	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5850555	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5844463	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5844463	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	83746000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	83664000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	84802000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	84941000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-144861000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-127293000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	23687000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	41312000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25017000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	45441000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8311000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14271000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12349000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9550000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5763000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4972000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1426000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-19287000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-20034000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-17321000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1719000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	926000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	119000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17568000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19108000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-17202000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17568000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19108000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17202000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.37
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.14
CY2023	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	5848737	shares
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	5671786	shares
CY2021	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	4159870	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	16378000	usd
CY2021	chek	Net Of Issuance Expenses Of Warrant Exercise NetOfIssuanceExpensesOfWarrantExercise	22000	usd
CY2021	chek	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	19219000	usd
CY2021	chek	Issuance Expenses Warrant Exercise Transaction IssuanceExpensesWarrantExerciseTransaction	3199000	usd
CY2021	chek	Stock And Warrant Issued During Period Value In Registered Direct Offering Two StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo	31801000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	491000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-17202000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	50691000	usd
CY2022	chek	Issuance Expenses Warrant Exercise Transaction IssuanceExpensesWarrantExerciseTransaction	1150000	usd
CY2022	chek	Stock And Warrant Issued During Period Value In Registered Direct Offering Two StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo	8850000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	879000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19108000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	41312000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-57000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17568000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	23687000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17568000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19108000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-17202000	usd
CY2023	us-gaap	Depreciation Depreciation	212000	usd
CY2022	us-gaap	Depreciation Depreciation	404000	usd
CY2021	us-gaap	Depreciation Depreciation	205000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1426000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	-57000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	879000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	491000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-305000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	624000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	49000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-480000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-273000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	549000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-851000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	207000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	362000	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-856000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-700000	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	451000	usd
CY2023	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	-94000	usd
CY2022	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	-38000	usd
CY2021	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	-22000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16954000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18707000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16264000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	83000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	486000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1006000	usd
CY2023	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	-21439000	usd
CY2022	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	12022000	usd
CY2021	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	15000000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	21356000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12508000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16006000	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	19219000	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	8850000	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	31801000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8850000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	51024000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	4402000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-22365000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	18754000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4442000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26807000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8053000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8844000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4442000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26807000	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	35000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	35000	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	161000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	307000	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	1048000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	25000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	5000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	33000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	2023000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	548000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	62000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8844000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4090000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26457000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	352000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	350000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8844000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4442000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26807000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17568000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19108000	usd
CY2023Q4	us-gaap	Retained Earnings Unappropriated RetainedEarningsUnappropriated	143191000	usd
CY2023	chek	Percentage Of Reducing Workforce PercentageOfReducingWorkforce	0.90	pure
CY2022Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 10 to 1 for 20
CY2022Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-20
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	48
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	18000000	shares
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of estimates in preparation of financial statements</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of financial statements in conformity with US GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates.</p>
CY2023	us-gaap	Derivatives Methods Of Accounting Hedging Derivatives DerivativesMethodsOfAccountingHedgingDerivatives	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr> <td style="width: 0.25in"> </td> <td style="vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.</b></span></td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash flow hedges</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5IN; text-align: justify">As a matter of policy, the Company uses derivatives for risk management purposes and does not use derivatives for speculative purposes. From time to time, the Company may enter into foreign currency zero-cost collars or minimal cost collars contracts to hedge foreign currency cash flow transactions. However, the company did not use such derivative as hedging for accounting purposes and thus the changes in fair value of the derivative were carried to profit and loss, as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5IN; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5IN; text-align: justify">As of December 31, 2023, the Company had no outstanding hedge transactions. As of December 31, 2022, the Company had outstanding foreign exchange collars in the notional amount of approximately $5,264. These options were set for a period of up to eight months as of December 31, 2022. The Company measured the fair value of the options in accordance with provisions of ASC No. 820 (classified as level 2 of the fair value hierarchy). The fair value of the Company’s outstanding collars on December 31, 2022 amounted to a liability, net of $56 and was included in other current liabilities.</p>
CY2022Q4	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	5264000	usd
CY2022Q4	chek	Fair Value Of Hedging Option FairValueOfHedgingOption	56000	usd
CY2023	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	1426000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	352000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	785	usd
CY2023Q4	chek	Prepaid Government Institutions PrepaidGovernmentInstitutions	44000	usd
CY2022Q4	chek	Prepaid Government Institutions PrepaidGovernmentInstitutions	88000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	35000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	260000	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	10000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	8000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	11000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	223000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	100000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	579000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3336000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3288000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1749000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1537000	usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1426000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	161000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1751000	usd
CY2023	chek	Sale Leaseback Transaction SaleLeasebackTransaction	8300	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	20000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	107000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	0	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	329000	usd
CY2023Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	142000	usd
CY2022Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	529000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	264000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	732000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	406000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1261000	usd
CY2023	chek	Deposits Rate DepositsRate	0.0833	pure
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	118512000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	27700000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	24232000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	27700000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	24232000	usd
CY2022Q4	chek	Royalties Provision RoyaltiesProvision	94000	usd
CY2022Q4	chek	Reported Price Amount ReportedPriceAmount	2200	usd
CY2021	chek	Final Grant Amount FinalGrantAmount	349000	usd
CY2022Q1	chek	Final Grant Amount FinalGrantAmount	82000	usd
CY2023Q1	chek	Final Grant Amount FinalGrantAmount	225000	usd
CY2021Q1	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	900	sqm
CY2021	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-01-31
CY2021	us-gaap	Lessor Operating Lease Option To Terminate LessorOperatingLeaseOptionToTerminate	90 days
CY2023Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	2600	usd
CY2023Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	2600	usd
CY2022Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	2500	usd
CY2022Q4	us-gaap	Foreign Currency Contracts Liability Fair Value Disclosure ForeignCurrencyContractsLiabilityFairValueDisclosure	56000	usd
CY2022Q4	chek	Financial Assets Liabilities Fair Value Disclosure FinancialAssetsLiabilitiesFairValueDisclosure	-53500	usd
CY2022Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-20
CY2015Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	8334	shares
CY2015Q1	us-gaap	Share Price SharePrice	1440
CY2015Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1656
CY2018Q2	chek	Offering Price OfferingPrice	110
CY2019Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	0.5	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	84626	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	84626	shares
CY2023Q4	us-gaap	Shares Issued SharesIssued	127.964	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P12M
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-57000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	975000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	491000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	15.7
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	1770000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1047000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	101000	usd
CY2023	us-gaap	Interest Expense InterestExpense	13000	usd
CY2022	us-gaap	Interest Expense InterestExpense	12000	usd
CY2021	us-gaap	Interest Expense InterestExpense	13000	usd
CY2023	chek	Changes In Liability To Pay Royalties ChangesInLiabilityToPayRoyalties	94000	usd
CY2022	chek	Changes In Liability To Pay Royalties ChangesInLiabilityToPayRoyalties	37000	usd
CY2021	chek	Changes In Liability To Pay Royalties ChangesInLiabilityToPayRoyalties	22000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-188000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-25000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-43000	usd
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	56000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-121000	usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	52000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1719000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	926000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	119000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17568000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19108000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-17202000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5848737	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5671786	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4159870	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.37
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.14
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	19000	usd
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	58000	usd
CY2021	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	61000	usd
CY2016Q2	chek	Employment Agreement Percentage EmploymentAgreementPercentage	0.50	pure
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2023Q4	chek	Royalties Provision RoyaltiesProvision		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent		usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.00
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.37
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.14
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4159870	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5671786	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5848737	shares
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense		usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1		usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2022	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf		usd
CY2021	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023Q4	chek	Royalties Provision RoyaltiesProvision		usd
CY2023Q4	chek	Royalties Provision RoyaltiesProvision		usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4159870	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5671786	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5848737	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.00
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.37
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.14
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001610590

Files In Submission

Name	View Source	Status
0001213900-24-043550-index-headers.html	Edgar Link	pending
0001213900-24-043550-index.html	Edgar Link	pending
0001213900-24-043550.txt	Edgar Link	pending
0001213900-24-043550-xbrl.zip	Edgar Link	pending
chek-20231231.xsd	Edgar Link	pending
ea0205895-20f_check.htm	Edgar Link	pending
ea020589501ex12-1_check.htm	Edgar Link	pending
ea020589501ex12-2_check.htm	Edgar Link	pending
ea020589501ex13-1_check.htm	Edgar Link	pending
ea020589501ex15-1_check.htm	Edgar Link	pending
ea020589501ex15-2_check.htm	Edgar Link	pending
ea020589501ex97-1_check.htm	Edgar Link	pending
ex15-1_001.jpg	Edgar Link	pending
ex15-1_002.jpg	Edgar Link	pending
ex15-2_001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fin_001.jpg	Edgar Link	pending
fin_002.jpg	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
image_012.jpg	Edgar Link	pending
image_013.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
chek-20231231_def.xml	Edgar Link	unprocessable
chek-20231231_lab.xml	Edgar Link	unprocessable
chek-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
chek-20231231_cal.xml	Edgar Link	unprocessable
ea0205895-20f_check_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CHEK
Check-Cap Ltd Stock $chek

2023 Q4 Form 20-F Financial Statement

#000121390024043550 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHEK Check-Cap Ltd Stock $chek

2023 Q4 Form 20-F Financial Statement

#000121390024043550 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHEK
Check-Cap Ltd Stock $chek